KEGG   DISEASE: Acetyl-CoA carboxylase-alpha deficiency
Entry
H02711                      Disease                                
Name
Acetyl-CoA carboxylase-alpha deficiency
Description
Acetyl-CoA carboxylase-alpha deficiency (ACACAD) is a rare autosomal recessive inborn error of metabolism caused by mutations in ACACA. ACACAD is characterized by hypotonia, motor and intellectual developmental delay. ACACA encodes acetyl-CoA carboxylase which is the rate-limiting enzyme in the de novo biosynthesis of fatty acids.
Category
Inherited metabolic disorder
Brite
Human diseases in ICD-11 classification [BR:br08403]
 05 Endocrine, nutritional or metabolic diseases
  Metabolic disorders
   Inborn errors of metabolism
    5C52  Inborn errors of lipid metabolism
     H02711  Acetyl-CoA carboxylase-alpha deficiency
Gene
ACACA [HSA:31] [KO:K11262]
Other DBs
ICD-11: 5C52.Y
MeSH: C562678
OMIM: 613933
Reference
  Authors
Lou X, Zhou X, Li H, Lu X, Bao X, Yang K, Liao X, Chen H, Fang H, Yang Y, Lyu J, Zheng H
  Title
Biallelic Mutations in ACACA Cause a Disruption in Lipid Homeostasis That Is Associated With Global Developmental Delay, Microcephaly, and Dysmorphic Facial  Features.
  Journal
Front Cell Dev Biol 9:618492 (2021)
DOI:10.3389/fcell.2021.618492
Reference
  Authors
Shafieipour N, Jafari Khamirani H, Kamal N, Tabei SMB, Dianatpour M, Dastgheib SA
  Title
The third patient of ACACA-related acetyl-CoA carboxylase deficiency with seizure and literature review.
  Journal
Eur J Med Genet 66:104707 (2023)
DOI:10.1016/j.ejmg.2023.104707
LinkDB

» Japanese version

DBGET integrated database retrieval system